Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery

Part of paid clinical trials in Washington D.C., District of Columbia.

Sponsor
George Washington University
Study ID
NCT06810375
Phase
PHASE3
Status
Recruiting
Apply to this trial

Conditions

  • Lung Cancers

Eligibility Criteria

Sex
ALL
Age
18 Years - 90 Years
Healthy Volunteers
Not accepted

Interventions

  • Erector Spinae (ESP) Block with Bupivacaine (Marcaine®) — DRUG
    preoperative erector spinae block with bupivacaine (Marcaine®)
  • Intercostal nerve block — DRUG
    intraoperative intercostal nerve block with liposomal bupivacaine (Exparel®)

Study Details

This clinical trial compares efficacy in postoperative pain management in thoracic surgery between erector spinae block versus liposomal bupivacaine injections.

Key Dates

Start date
Mar 1, 2025
Status verified
Apr 2026
Primary completion
Feb 28, 2028
Completion
Feb 28, 2029

Study Design

Enrollment
120 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Preoperative Erector Spinae Block (ESB)(Bupivacaine)(Marcaine®)
  • Active Comparator: Intraoperative Intercostal Nerve Block (INB)(Liposomal Bupivacaine)(Exparel®)

Primary Outcome Measure

Postoperative pain control assessment [ Time Frame: Up to 48 hours postoperatively ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
The George Washington University HospitalWashington D.C.District of Columbia20037
Eduard Shaykhinurov
[email protected]
202-203-8960

Find similar trials in Washington D.C., DC

By research site
The George Washington University Hospital· Washington D.C., DC

Related Studies